The therapeutic potential of recombinant human insulin‐like growth factor‐I
- 1 July 1992
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 37 (1) , 11-16
- https://doi.org/10.1111/j.1365-2265.1992.tb02277.x
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Who's for growth hormone?BMJ, 1992
- Biochemical and hormonal changes induced by one week of administration of rIGF‐I to patients with Laron type dwarfismClinical Endocrinology, 1991
- The presence of cation‐dependent proteases for insulin‐like growth factor binding proteins does not alter the size distribution of insulin‐like growth factors in pregnancyClinical Endocrinology, 1991
- Effects of the Infusion of Insulin-like Growth Factor I in a Child with Growth Hormone Insensitivity Syndrome (Laron Dwarfism)New England Journal of Medicine, 1991
- Treatment of short normal children with growth hormone—a cautionary tale?The Lancet, 1990
- Laron Dwarfism and Mutations of the Growth Hormone–Receptor GeneNew England Journal of Medicine, 1989
- Binding proteins for the insulin-like growth factors: Structure, regulation and functionProgress in Growth Factor Research, 1989
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsNew England Journal of Medicine, 1987
- Impaired Insulin Action in PubertyNew England Journal of Medicine, 1986
- Insulin-Infusion-Pump Treatment of DiabetesNew England Journal of Medicine, 1981